Next Generation Sequencing based ctDNA Profiling as a...
Introduction Advanced melanoma remains a highly aggressive malignancy in which immune checkpoint inhibitors (ICIs) have transformed patient outcomes, yet resistance and heterogeneous treatment responses persist. Many clinical assays rely either on tumour informed strategies requiring...